| P50 | author | Richard Moriggl | Q38327183 |
| | Boris Kovacic | Q42847409 |
| | Lothar Hennighausen | Q51971727 |
| P2093 | author name string | Hartmut Beug | |
| | Veronika Sexl | |
| | Marc A Kerenyi | |
| | Wolfgang Warsch | |
| | Yongzhi Cui | |
| | Olivia Simma | |
| | Andrea Hoelbl | |
| P2860 | cites work | A role for Stat5 in CD8+ T cell homeostasis. | Q52008748 |
| | Stat5 is essential for the myelo- and lymphoproliferative disease induced by TEL/JAK2 | Q57054898 |
| | Jak1 deficiency leads to enhanced Abelson-induced B-cell tumor formation | Q58029707 |
| | Stat5 tetramer formation is associated with leukemogenesis | Q58326863 |
| | The IL-7 receptor controls the accessibility of the TCRgamma locus by Stat5 and histone acetylation | Q77307375 |
| | STAT5 activation by BCR-Abl contributes to transformation of K562 leukemia cells | Q78039810 |
| | Cell intrinsic defects in cytokine responsiveness of STAT5-deficient hematopoietic stem cells | Q78409855 |
| | Osteopontin is upregulated by BCR-ABL | Q81917793 |
| | Stat5 is required for IL-2-induced cell cycle progression of peripheral T cells | Q22009002 |
| | TYK2 is a key regulator of the surveillance of B lymphoid tumors | Q24559982 |
| | A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera | Q28241887 |
| | Constitutive activation of STAT5 by the BCR-ABL oncogene in chronic myelogenous leukemia | Q28285018 |
| | Stat5a/b contribute to interleukin 7-induced B-cell precursor expansion, but abl- and bcr/abl-induced transformation are independent of stat5 | Q28508796 |
| | Stat5 activation is uniquely associated with cytokine signaling in peripheral T cells | Q28511057 |
| | Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses | Q28592023 |
| | STAT5 is required for thymopoiesis in a development stage-specific manner | Q28592686 |
| | RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement | Q28594711 |
| | Stats: transcriptional control and biological impact | Q29547776 |
| | Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis | Q29614337 |
| | Signal transducer and activator of transcription (STAT)5 activation by BCR/ABL is dependent on intact Src homology (SH)3 and SH2 domains of BCR/ABL and is required for leukemogenesis | Q30175784 |
| | Reduced lymphomyeloid repopulating activity from adult bone marrow and fetal liver of mice lacking expression of STAT5. | Q33183255 |
| | Proliferation of adult T cell leukemia/lymphoma cells is associated with the constitutive activation of JAK/STAT proteins | Q33734222 |
| | Physiological significance of STAT proteins: investigations through gene disruption in vivo | Q33754086 |
| | The role of Stat5a and Stat5b in signaling by IL-2 family cytokines | Q33941389 |
| | B-cell commitment, development and selection | Q33996192 |
| | Stat proteins and oncogenesis | Q34627064 |
| | B-cell commitment: deciding on the players | Q35084264 |
| | STAT proteins: From normal control of cellular events to tumorigenesis | Q35540165 |
| | A new modality for immunosuppression: targeting the JAK/STAT pathway | Q35825869 |
| | STAT proteins as novel targets for cancer drug discovery | Q35911116 |
| | Signal transducer and activator of transcription (STAT) signalling and T-cell lymphomas. | Q36048656 |
| | Hematopoietic stem cells and their niche. | Q36175339 |
| | The JAK2V617F tyrosine kinase mutation in myeloproliferative disorders: status report and immediate implications for disease classification and diagnosis | Q36189058 |
| | A role for niches in hematopoietic cell development | Q36194591 |
| | Developmental regulation of lck gene expression in T lymphocytes | Q36229919 |
| | Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice | Q36364066 |
| | Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl | Q36365946 |
| | A novel element upstream of the Vgamma2 gene in the murine T cell receptor gamma locus cooperates with the 3' enhancer to act as a locus control region | Q36375288 |
| | Stat5 synergizes with T cell receptor/antigen stimulation in the development of lymphoblastic lymphoma | Q36376661 |
| | IL-7 receptor signaling is necessary for stage transition in adult B cell development through up-regulation of EBF. | Q36403451 |
| | Inactivation of Stat5 in mouse mammary epithelium during pregnancy reveals distinct functions in cell proliferation, survival, and differentiation | Q37493064 |
| | Inhibition of Bcr-Abl kinase activity by PD180970 blocks constitutive activation of Stat5 and growth of CML cells | Q38359739 |
| | STAT5 promotes multilineage hematolymphoid development in vivo through effects on early hematopoietic progenitor cells | Q39122429 |
| | Loss of Tolerance and Autoimmunity Affecting Multiple Organs inSTAT5A/5B-Deficient Mice | Q39127345 |
| | Activated STAT5 proteins induce activation of the PI 3-kinase/Akt and Ras/MAPK pathways via the Gab2 scaffolding adapter | Q40434680 |
| | Constitutively active STAT5 variants induce growth and survival of hematopoietic cells through a PI 3-kinase/Akt dependent pathway. | Q40804665 |
| | Bcr/Abl activates transcription of the Bcl-X gene through STAT5. | Q40856047 |
| | STAT5-Dependent CyclinD1 and Bcl-xL expression in Bcr-Abl-transformed cells | Q40858154 |
| | STAT5 activation contributes to growth and viability in Bcr/Abl-transformed cells. | Q40895248 |
| | Physiologic roles of interleukin-2, interleukin-4, and interleukin-7. | Q41645019 |
| | Activated Stat related transcription factors in acute leukemia | Q41719633 |
| | Functional cooperation among Ras, STAT5, and phosphatidylinositol 3-kinase is required for full oncogenic activities of BCR/ABL in K562 cells | Q43847051 |
| | JAK2 in myeloproliferative disorders is not just another kinase. | Q46560527 |
| | STAT5 activation underlies IL7 receptor-dependent B cell development | Q47810418 |
| | Functional dissection of the murine lck distal promoter | Q48071793 |
| | Restricted STAT5 activation dictates appropriate thymic B versus T cell lineage commitment. | Q50966213 |
| | Distinct effects of STAT5 activation on CD4+ and CD8+ T cell homeostasis: development of CD4+CD25+ regulatory T cells versus CD8+ memory T cells. | Q52004102 |
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 4898-4906 | |
| P577 | publication date | 2006-02-21 | |
| P1433 | published in | Blood | Q885070 |
| P1476 | title | Clarifying the role of Stat5 in lymphoid development and Abelson-induced transformation | |
| P478 | volume | 107 | |